Research Study for Cocaine-Dependent Individuals. Comp up to $2400

Research Study for Cocaine-Dependent Individuals. Comp up to $2400 CONFIDENTIAL Research Study at Weill Cornell Medicine/ New York Presbyterian Hospital The study is a phase I dose-ranging, placebo-controlled, double-blind study assessing the safety and preliminary efficacy of a vaccine for cocaine dependence. It is a 32-week research study that includes 6 doses of an investigational vaccine or placebo. Qualified participants may receive study-related tests and individual counseling with a behavioral therapist. Compensation for participation: Up to $2400 • Principals only. Recruiters, please don't contact this job poster. • do NOT contact us with unsolicited services or offers